Affiliation:
1. Louisiana State University Medical Center, Department of Physiology, New Orleans 70112-2822
Abstract
Abstract
Correlation between coronary heart disease and lipoprotein size and composition is well documented. Within the low-density lipoprotein (LDL) family the small LDL particles are associated with increased risk of coronary heart disease. These particles also have increased apolipoprotein (apo) B content. The appearance of these small LDL particles is the manifestation of complex alteration of plasma lipoprotein metabolism. The LDL size is influenced by genetic, endocrine, and environmental factors. Within the high-density lipoprotein (HDL) family the decrease of larger HDL2 particles is associated with coronary heart disease. HDLs can also be separated according to their apoprotein composition into particles containing lipoprotein (Lp)A-I only and particles containing LpA-I and LpA-II. Most studies have shown that the concentration of LpA-I-only particles decreases in coronary heart disease. HDLs are remodeled in the circulation and this remodeling continues in vitro after the blood is taken. Therefore adequate preservation of blood samples is necessary.
Publisher
Oxford University Press (OUP)
Subject
Biochemistry (medical),Clinical Biochemistry
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Diabetes and Cardiovascular Disease;Handbook of Cardiovascular Behavioral Medicine;2022
2. Lipid metabolism and disorders;Clinical Chemistry, Immunology and Laboratory Quality Control;2021
3. Remnant lipoprotein size distribution profiling via dynamic light scattering analysis;Clinica Chimica Acta;2016-11
4. Lipid Metabolism and Disorders;Clinical Chemistry, Immunology and Laboratory Quality Control;2014
5. Particle size measurement of lipoprotein fractions using diffusion-ordered NMR spectroscopy;Analytical and Bioanalytical Chemistry;2012-02-01